M&A Deal Summary |
|
|---|---|
| Date | 2001-08-20 |
| Target | Cook Pharmaceutical Solutions |
| Sector | Medical Products |
| Buyer(s) | Baxter International |
| Sellers(s) | Cook Group |
| Deal Type | Divestiture |
| Deal Value | 219M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1931 |
| Sector | Medical Products |
| Employees | 38,000 |
| Revenue | 10.6B USD (2024) |
Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 20 |
| Sector: Medical Products M&A | 1 of 12 |
| Type: Divestiture M&A Deals | 1 of 6 |
| State: Indiana M&A | 1 of 1 |
| Country: United States M&A | 3 of 14 |
| Year: 2001 M&A | 1 of 1 |
| Size (of disclosed) | 12 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1998-05-04 |
Somatogen
Boulder, California, United States Somatogen, Inc is a biopharmaceutical company developing recombinant hemoglobin-based products. |
Buy | $189M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-05-03 |
Fusion Medical Technologies
Fremont, California, United States Fusion Medical Technologies, Inc. expertise in developing and commercializing proprietary products used to control bleeding during surgery. |
Buy | $157M |
| Category | Company |
|---|---|
| Founded | 1963 |
| Sector | Medical Products |
Cook Group, Inc. provides services in developing health care devices that have improved lives around the world. With sales and marketing offices worldwide, we are at the forefront of medical research and product development in minimally invasive medical device technology for diagnostic and therapeutic procedures.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Medical Products M&A | 1 of 2 |
| Type: Divestiture M&A Deals | 1 of 2 |
| State: Indiana M&A | 1 of 2 |
| Country: United States M&A | 1 of 2 |
| Year: 2001 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-08 |
Cook Biotech
West Lafayette, Indiana, United States Cook Biotech develops and manufactures SIS products for a variety of clinical applications; these products have over 50 cleared regulatory indications. Cook Biotech's products are derived from SIS's naturally occurring, intact extracellular matrix (ECM) using proprietary manufacturing processes. Cook Biotech was founded in 1995 and is based in West Lafayette, Indiana. |
Sell | - |
